Jason Cohen, Editor

About the Author Jason Cohen, Editor


Check-Cap (CHECK): What the Hell Has Happened

Medical diagnostics company Check Cap (NASDAQ:CHEK) is a puzzle. In the last two trading days, …

vTv Therapeutics (VTVT) Stock: Healthcare Analysts Move to the Sidelines

Last week, vTv Therapeutics Inc (NASDAQ:VTVT) announced that azeliragon, the company’s RAGE inhibitor in development …

Bristol Myers Squibb (BMY) Will Face Significant Headwinds in 2019; Here’s Why

Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small …

Why GW Pharmaceuticals (GWPH) Stock Is Posting Strong Gains Today

GW Pharmaceuticals (NASDAQ:GWPH) is a mover and shaker out on the Street today, with investors …

J.P. Morgan Shares Two Cents on Dynavax Technologies’ (DVAX) AACR Update

J.P. Morgan analyst Anupam Rama is out today with a brief research note on shares of Dynavax …

TherapeuticsMD’s (TXMD) TX-004 Takes a Step Forward to FDA Approval, Says Cantor

TherapeuticsMD (NASDAQ:TXMD) investors have a smile on their faces Wednesday, after the drug maker disclosed that …

Acadia Pharmaceuticals (ACAD): Another Glimpse Into Nuplazid Safety Profile

Acadia Pharmaceuticals (NASDAQ:ACAD) is a biopharmaceutical company based in San Diego and focused on the …

AveXis (AVXS) Takeover Validates the Paradigm-Shifting Nature of AVXS-101, Says William Blair

It’s a big day for AveXis (NASDAQ:AVXS). The drug maker has reached an agreement to be acquired …

Guggenheim Bullish on Menlo Therapeutics (MNLO) Despite Clinical Trial Setback

Small-cap biotech stocks are often considered “binary” lottery-ticket type events, with either a small chance …

Incyte (INCY) Shares Remain Attractive, Says Top Analyst

This morning, Incyte (NASDAQ:INCY) announced that the company’s ECHO-301 study comparing epacadostat in combination with …